Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model

Otolaryngology - Head and Neck Surgery (United States)

Volumn 150, Issue 1, 2014, Pages 115-120

  Hughes, Amy Lawrason ^a   Hussain, Nighat ^a   Pafford, Ryan ^a   Parham, Kourosh ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

cisplatin; murine model; ototoxicity; sensorineural hearing loss

Indexed keywords

CISPLATIN; DEXAMETHASONE; DEXAMETHASONE 21PHOSPHATE DISODIUM SALT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG MEGADOSE; EAR PROTECTION; EVOKED AUDITORY RESPONSE; EVOKED BRAIN STEM RESPONSE; FEMALE; MOUSE; MULTIPLE CYCLE TREATMENT; MURINE MODEL; NONHUMAN; OTOTOXICITY; PURE TONE AUDIOMETRY; SINGLE DRUG DOSE; TRANSLATIONAL RESEARCH; TREATMENT DURATION;

EID: 84890828915     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813511948     Document Type: Article

References (33)

1. Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today. 2005 ; 10: 1313-1321 (Pubitemid 41416704)
2. Garcia-Berrocal JR, Nevado J, Ramirez-Camacho R, et al. The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear. Br J Pharmacol. 2007 ; 152: 1012-1020 (Pubitemid 350166041)
3. Waters GS, Ahmad M, Katsarkas A, Stanimir G, McKay J. Ototoxicity due to cis-diamminedichloro-platinum in the treatment of ovarian cancer: influence of dosage and administration. Ear Hear. 1991 ; 12: 91-102
4. Laurell G, Jungnelius U. High-dose cisplatin treatment: hearing loss and plasma concentrations. Laryngoscope. 1990 ; 100: 724-734 (Pubitemid 20222873)
5. Blakley BW, Gupta AK, Myers SF, Schwan S. Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg. 1994 ; 120: 541-546 (Pubitemid 24142680)
6. Mukherjea D, Jajoo S, Sheehan KE, et al. NOX3 NADPH Oxidase couples transient receptor potential Vanilloid 1 to STAT1-mediated inflammation and hearing loss. Antioxid Redox Signal. 2011 ; 14: 999-1010
7. Alam SA, Ikeda K, Oshima T, et al. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res. 2000 ; 141: 28-38 (Pubitemid 30125313)
8. Lee JE, Nakagawa T, Kim TS, et al. A novel model for rapid induction of apoptosis in spiral ganglions of mice. Laryngoscope. 2003 ; 113: 994-999 (Pubitemid 36676596)
9. Lee JE, Nakagawa T, Kita T, et al. Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis. ORL J Otorhinolaryngol Relat Spec. 2004 ; 66: 111-118 (Pubitemid 39194336)
10. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res. 2007 ; 226: 157-167 (Pubitemid 46428033)
11. Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fund Appl Toxicol. 1995 ; 26: 293-300
12. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol. 1995 ; 76: 386-394
13. Wang J, Lloyd Faulconbridge RV, Fetoni A, et al. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology. 2003 ; 45: 380-393 (Pubitemid 36836134)
14. Wimmer C, Mees K, Stumpf P, et al. Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol. 2004 ; 25: 33-40 (Pubitemid 39077568)
15. Park SK, Choi D, Russell P, John EO, Jung TT. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope. 2004 ; 114: 768-771 (Pubitemid 38548795)
16. Palmer RM, Bridge L, Foxwell NA, Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol. 1992 ; 105: 11-20
17. Himeno C, Komeda M, Izumikawa M, et al. Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res. 2002 ; 167: 61-70 (Pubitemid 34756851)
18. Hill GW, Morest DK, Parham K. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections. Otol Neurotol. 2008 ; 29: 1005-1011
19. Parham K. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?. Otolaryngol Head Neck Surg. 2011 ; 145: 635-640
20. Murphy D, Daniel SJ. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model. Otolaryngol Head Neck Surg. 2011 ; 145: 452-457
21. Paksoy M, Ayduran E, SanlI A, Eken M, AydIn S, Oktay ZA. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol. 2011 ; 28: 615-621
22. Daldal A, Odabasi O, Serbetcioglu B. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg. 2007 ; 137: 747-752 (Pubitemid 47632918)
23. Parham K. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?. Otolaryngol Head Neck Surg. 2011 ; 145: 635-640
24. Rutherford KD, Kavanagh K, Parham K. Auditory function after application of ototopical vancomycin and mupirocin solutions in a murine model. Otolaryngol Head Neck Surg. 2010 ; 144: 419-426
25. Hyppolito MA, de Oliveira JA, Rossato M. Cisplatin ototoxicity and otoprotection with sodium salicylate. Eur Arch Otorhinolaryngol. 2006 ; 263: 798-803 (Pubitemid 44127303)
26. Minami SB, Sha SH, Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear Res. 2004 ; 198: 137-143 (Pubitemid 39536163)
27. Poirrier AL, Van den Ackerveken P, Kim TS, et al. Ototoxic drugs: difference in sensitivity between mice and guinea pigs. Toxicol Lett. 2010 ; 193: 41-49
28. Qureshy K, Blakley B, Alsaleh S, Quddusi T, Berard S. End points for cisplatin ototoxicity. Otolaryngol Head Neck Surg. 2011 ; 40: S45 - S48
29. Roehm P, Hoffer M, Balaban CD. Gentamicin uptake in the chinchilla inner ear. Hear Res. 2007 ; 230: 43-52 (Pubitemid 47058837)
30. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol. 2006 ; 27: 564-569
31. Nakamagoe M, Tabuchi K, Uemaetomari I, Nishimura B, Hara A. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway. Hear Res. 2010 ; 261: 67-74
32. Trune DR, Kempton JB, Kessi M. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice. Laryngoscope. 2000 ; 11: 1902-1906
33. Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res. 2006 ; 212: 22-32 (Pubitemid 43254933)